Literature DB >> 10738011

Risk factors for exacerbations and hospital admissions in asthma of early childhood.

J Wever-Hess1, J M Kouwenberg, E J Duiverman, J Hermans, A M Wever.   

Abstract

Hospital admissions and readmissions for asthma in early childhood remain causes for concern. The purpose of this study was to identify predisposing risk factors related to asthma exacerbations and precursors of hospital admissions in young children. Subjects were patients with doctor-diagnosed asthma from a clinical registration study, aged 0-4 years, and followed up for 2 years. Data from histories and laboratory tests for atopic status at initial presentation, and the patient's condition at visits over the 2-year follow-up period were evaluated. Exacerbation was defined as increases in cough and/or wheeze and/or breathlessness, increase in beta(2)-agonist use, and a clinical need for a short course of oral corticosteroids. Age groups 0-1 year and 2-4 years, based on age at initial presentation, were analyzed separately. In the age group 0-1 year, 71/113 (63%) patients had at least one exacerbation, and 20 experienced recurrent exacerbations (>/=3). Predisposing risk factors for exacerbation were damp housing (odds ratio (OR) 7.6 (2. 0-28.6)) and colds (OR 3.6 (1.4-9.6)), and for recurrent exacerbations sensitization to inhalant allergens (Phadiatop(R)) (OR 8.1 (1.6-40.5)) and damp housing (OR 3.8 (1.1-12.8)). Hospital admissions were significantly associated with number of exacerbations. In the age group 2-4 years, 58/144 (40%) patients had at least one exacerbation, and 21 experienced recurrent exacerbations (>/=2). Predisposing risk factors for exacerbation were mean age at initial presentation (OR 0.92 (0.88-0.97)) and level of total IgE (OR 2.3 (1.4-3.9)), whereas for recurrent exacerbations no predictor variables were found. Hospital admissions were significantly associated with damp housing. Results from this study may facilitate recognition of young asthmatic patients at risk of (recurrent) exacerbations, and help to identify those in whom early intervention with anti-inflammatory therapy may be necessary. We also emphasize the importance of preventive measures in decreasing damp housing. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738011     DOI: 10.1002/(sici)1099-0496(200004)29:4<250::aid-ppul3>3.0.co;2-4

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

Review 1.  Asthma outcomes: exacerbations.

Authors:  Anne Fuhlbrigge; David Peden; Andrea J Apter; Homer A Boushey; Carlos A Camargo; James Gern; Peter W Heymann; Fernando D Martinez; David Mauger; William G Teague; Carol Blaisdell
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

2.  Modeling asthma exacerbations through lung function in children.

Authors:  Ann Chen Wu; Martin Gregory; Steven Kymes; Dennis Lambert; Joshua Edler; Dustin Stwalley; Anne L Fuhlbrigge
Journal:  J Allergy Clin Immunol       Date:  2012-09-27       Impact factor: 10.793

3.  Predictors of poor response during asthma therapy differ with definition of outcome.

Authors:  Angela J Rogers; Kelan G Tantisira; Anne L Fuhlbrigge; Augusto A Litonjua; Jessica A Lasky-Su; Stanley J Szefler; Robert C Strunk; Robert S Zeiger; Scott T Weiss
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

4.  Asthma severity and atopy: how clear is the relationship?

Authors:  W D Carroll; W Lenney; F Child; R C Strange; P W Jones; M K Whyte; R A Primhak; A A Fryer
Journal:  Arch Dis Child       Date:  2006-01-27       Impact factor: 3.791

Review 5.  Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review.

Authors:  Huong Duong-Thi-Ly; Ha Nguyen-Thi-Thu; Long Nguyen-Hoang; Hanh Nguyen-Thi-Bich; Timothy J Craig; Sy Duong-Quy
Journal:  J Int Med Res       Date:  2017-01-25       Impact factor: 1.671

6.  Sensitization profile in differential diagnosis: allergic asthma vs. chronic (nonspecific) cough syndrome.

Authors:  Vlado Drkulec; Boro Nogalo; Marija Perica; Davor Plavec; Marija Pezer; Mirjana Turkalj
Journal:  Med Sci Monit       Date:  2013-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.